Viewing Study NCT00153933


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2025-12-26 @ 1:35 AM
Study NCT ID: NCT00153933
Status: COMPLETED
Last Update Posted: 2016-01-25
First Post: 2005-09-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module